Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Affitech AS

www.affitech.com

Latest From GE OEC Medical Systems Inc.

Amir Belson: Stealth Medtech Entrepreneur

Amir Belson is among the most prolific device entrepreneurs in the industry today, having launched a dozen companies in the past 12 years. Not as well-known as other physician-inventors, he combines an aggressive IP strategy with an innovative approach to early-stage financing to launch companies in a variety of clinical spaces.

Medical Device Innovation

The Interventional Suite Of The Future

The cardiac interventional suite has historically welcomed high-tech, cutting-edge tools. But with hospitals scrutinizing expenditures more closely than ever before, such tools must now prove themselves. Hospitals are now placing a premium on technologies that can improve safety, efficiency, and flexibility while streamlining workflow. A handful of companies are now offering products designed to meet these needs, and providers are starting to take notice.

Medical Device

Image-Guided Focused Ultrasound Gains Ground As Noninvasive Therapeutic Tool

Research into the use of image-guided focused ultrasound (IgFUS) as a noninvasive therapeutic modality is starting to achieve the kind of critical mass - in clinical outcomes data and R&D investment - necessary to win the interest and support of clinicians, payors, and regulators. Although there is still a good distance to travel before the technology achieves a routine place in the therapeutic toolkit, IgFUS is clearly an up-and-coming field in the medical device arena, and many believe it has the potential to revolutionize the treatment paradigm in a number of clinical areas.

The Interventional Suite Of The Future

The cardiac interventional suite has historically been a setting where high-tech, cutting-edge tools are welcomed. But with hospitals scrutinizing expenditures more closely than ever before, such tools must now prove themselves. Hospitals looking to build new interventional suites, or modernize old ones, are placing a premium on technologies that can improve safety, efficiency, and flexibility while streamlining workflow. A handful of companies are now offering products designed to meet these needs, and providers are starting to take notice.
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Norway
  • Parent & Subsidiaries
  • Affitech AS
  • Senior Management
  • Robert Burns, PhD, CEO
    Hans Petter Tjeldflaat, Dir., Fin.
    Michael Braunagel, PhD, Dir., Strategic Alliances & Lic.
    Rathin C Das, PhD, SVP, Corp. Dev.
    Alexander Duncan, PhD, SVP, R&D
  • Contact Info
  • Affitech AS
    Phone: (47) 22 95 87 58
    Gaustadalléen 21
    Oslo, N-0349
    Norway
Advertisement
Advertisement
UsernamePublicRestriction

Register